Hospitals
The greater Seattle metropolitan region is served by approximately 243 hospitals and primary care facilities.
Description
The Seattle life sciences ecosystem has solidified its status as a premier global hub, defined by a unique convergence of biotechnology, computational biology and healthcare innovation.
Renowned as a world leader in immunotherapy and cell therapy, the region is anchored by prestigious institutions such as the University of Washington and the Fred Hutchinson Cancer Center.
Seattle’s biopharmaceutical sector continues to thrive, with major players like Pfizer and Bristol Myers Squibb expanding their footprint through strategic acquisitions and high-spec biomanufacturing facilities.
Beyond therapeutics, the "Emerald City" is a pioneer in medical device technologies, particularly in advanced imaging and diagnostic tools developed within the Bothell innovation zone.
The ecosystem’s distinct edge lies in its integration of artificial intelligence (AI) with deep biological expertise, driving breakthroughs in precision medicine and genomics.
Supported by a robust pipeline of venture capital and over 9 million ft² of dedicated R&D lab space, Seattle attracts top-tier scientific talent and global investment. From global health initiatives led by the Bill & Melinda Gates Foundation to agile healthtech startups, the region’s collaborative culture accelerates the journey from lab bench to bedside.
As a top-ten US life sciences cluster, Seattle remains at the forefront of tackling the world’s most complex medical challenges.
Featured Editorial
Regions
Universities
The University of Washington (Seattle campus) is an R1 institution and a member of the Association of American Universities (AAU). Other notable universities include Seattle University, Seattle Pacific University, Northwest University and City University of Seattle.
Government Funding
Institutions in the Seattle area received approximately $1.13 billion in NIH funding for fiscal year ending Q3 2024.
VC Funding
In 2024, life sciences companies based in Seattle collectively raised more than $700 million in VC funding.
Life Science Firms
The region is home to more than 1,180 life science companies, placing it among the top 10 life science clusters in the US.
Big Pharma Presence
Giants like Bristol Myers Squibb (BMS), Novo Nordisk and Pfizer have a tangible presence in Seattle, contributing significantly to research and employment in the region. Seattle also supports a vibrant network of biotech and pharma startups, including names like Adaptive Biotechnologies, Nautilus Biotechnology, Umoja Biopharma, Dendreon and others.
Big Medtech Presence
Some medtech companies with a presence in Seattle include Pathware, Wavely Diagnostics, Phoresa and many others.
Active Clinical Studies
There are currently around 2,355 clinical studies being conducted in the Seattle area.
